Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

Summary

Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.

Lotu Radar provides attributed news summaries and links to the original publisher. Full reporting and copyright remain with the source.